As one of the most talked-about breakthroughs in medical weight loss, Semaglutide (sold under brand names like Wegovy and Ozempic) is a GLP-1 weight loss treatment that helps regulate appetite, improve blood sugar levels, and promote sustainable weight loss when paired with lifestyle changes
LDN specifically targets inflammation and immune modulation, while GLP-1 agonists enhance metabolic control, but also have anti-inflammatory properties
Shima Hadidchi, MD, Explains the Difference
The downsides of microdosing are its unknown effectiveness, sometimes increased risk of side effects because of non-monitoring, the potential for overdose due to overconsumption, and no guarantee of quality
Thats when you know it is good
Schumer has been candid about her experience trying various weight-loss drugs, opening up in March about Mounjaro a GLP-1 drug similar to Ozempic